IL13RA2 and malignant colon neoplasm: Though our phenotypic data contradict those reported by the Casal group for colon cancer [18, 19, 45, 46], the pathways identified as differentially active in IL13RA2-deficient cells, namely, AKT, NF-κB, and focal adhesion, overlap.